Genomic characterization and early macrophage inflammatory responses to an emerging Mycobacterium wolinskyi isolate

Mycobacterium wolinskyi is an emerging rapidly growing nontuberculous mycobacterium increasingly recognized as a cause of skin, soft-tissue, and device-associated infections, including infections in immunocompetent individuals. However, its genomic characteristics and interactions with host immune cells remain poorly understood. In this study, we characterized a clinical M. wolinskyi isolate, designated QL01, recovered from a facial skin infection in an 11-year-old child, by combining antimicrobial susceptibility testing, whole-genome sequencing, comparative genomic analysis, and macrophage infection assays with transcriptomic profiling. QL01 was resistant to clarithromycin, imipenem, and trimethoprim-sulfamethoxazole, while remaining susceptible to amikacin, linezolid, moxifloxacin, minocycline, and doxycycline. Whole-genome sequencing generated a complete circular chromosome and identified antimicrobial resistance-associated homologs and host interaction-associated homologs. Comparative analysis revealed variable conservation of type VII secretion system (T7SS)- and Mce-associated loci among representative rapidly growing mycobacteria. Following uptake by mouse bone marrow-derived macrophages, viable intracellular QL01 remained recoverable after 24 h. RNA sequencing revealed an early innate immune and pro-inflammatory transcriptional response, with enrichment of TNF, NF-κB, Toll-like receptor, and C-type lectin receptor signaling pathways. RT-qPCR further confirmed increased expression of Ccl2 , Tnf , Il1b , Tlr2 , Clec4e , and Tnfaip3 . ELISA confirmed increased secretion of TNF-α, IL-1β, and IFN-β. Inhibition of IKK/NF-κB signaling attenuated QL01-induced phosphorylation of p65 and IκBα and reduced inflammatory cytokine secretion. These findings characterize the genomic features of a clinical M. wolinskyi isolate and describe the early macrophage response to this emerging nontuberculous mycobacterial species.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2026-11-11
DOI
https://doi.org/10.3389/fmicb.2026.2014277
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genomic characterization and early macrophage inflammatory responses to an emerging Mycobacterium wolinskyi isolate

Shixuan Wei, Xiaoli Zhang, Hongwei Pan, Enhua Sun et al.
Frontiers in Microbiology
Mycobacterium research and diagnosis
article

Genomic characterization and early macrophage inflammatory responses to an emerging Mycobacterium wolinskyi isolate

Shixuan Wei, Xiaoli Zhang, Hongwei Pan, Enhua Sun, Yonghao Xu, Yiwen Gao, Lili Wang, Weiwei Sun, Zhihong Wu, Yuxiao Zhao, Wei Li
article en

Abstract

Mycobacterium wolinskyi is an emerging rapidly growing nontuberculous mycobacterium increasingly recognized as a cause of skin, soft-tissue, and device-associated infections, including infections in immunocompetent individuals. However, its genomic characteristics and interactions with host immune cells remain poorly understood. In this study, we characterized a clinical M. wolinskyi isolate, designated QL01, recovered from a facial skin infection in an 11-year-old child, by combining antimicrobial susceptibility testing, whole-genome sequencing, comparative genomic analysis, and macrophage infection assays with transcriptomic profiling. QL01 was resistant to clarithromycin, imipenem, and trimethoprim-sulfamethoxazole, while remaining susceptible to amikacin, linezolid, moxifloxacin, minocycline, and doxycycline. Whole-genome sequencing generated a complete circular chromosome and identified antimicrobial resistance-associated homologs and host interaction-associated homologs. Comparative analysis revealed variable conservation of type VII secretion system (T7SS)- and Mce-associated loci among representative rapidly growing mycobacteria. Following uptake by mouse bone marrow-derived macrophages, viable intracellular QL01 remained recoverable after 24 h. RNA sequencing revealed an early innate immune and pro-inflammatory transcriptional response, with enrichment of TNF, NF-κB, Toll-like receptor, and C-type lectin receptor signaling pathways. RT-qPCR further confirmed increased expression of Ccl2 , Tnf , Il1b , Tlr2 , Clec4e , and Tnfaip3 . ELISA confirmed increased secretion of TNF-α, IL-1β, and IFN-β. Inhibition of IKK/NF-κB signaling attenuated QL01-induced phosphorylation of p65 and IκBα and reduced inflammatory cytokine secretion. These findings characterize the genomic features of a clinical M. wolinskyi isolate and describe the early macrophage response to this emerging nontuberculous mycobacterial species.

Frontiers in MicrobiologyVol. 17
Qilu Hospital of Shandong University (CN)
Mycobacterium research and diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon